These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9788576)

  • 1. Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma.
    Takeuchi H; Ara G; Sausville EA; Teicher B
    Cancer Chemother Pharmacol; 1998; 42(6):491-6. PubMed ID: 9788576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton.
    Senderowicz AM; Kaur G; Sainz E; Laing C; Inman WD; Rodríguez J; Crews P; Malspeis L; Grever MR; Sausville EA
    J Natl Cancer Inst; 1995 Jan; 87(1):46-51. PubMed ID: 7666463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Radiat Oncol Investig; 1998; 6(2):71-80. PubMed ID: 9572683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia.
    Ryu S; Brown SL; Kim SH; Khil MS; Kim JH
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):133-8. PubMed ID: 12118542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
    Teicher BA; Wong JS; Takeuchi H; Gravelin LM; Ara G; Buxton D
    Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of tomudex with radiation in vitro and in vivo.
    Teicher BA; Ara G; Chen YN; Recht A; Coleman CN
    Int J Oncol; 1998 Sep; 13(3):437-42. PubMed ID: 9683775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo.
    Asea A; Ara G; Teicher BA; Stevenson MA; Calderwood SK
    Int J Hyperthermia; 2001; 17(4):347-56. PubMed ID: 11471985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin disruption inhibits bombesin stimulation of focal adhesion kinase (pp125FAK) in prostate carcinoma.
    Duncan MD; Harmon JW; Duncan LK
    J Surg Res; 1996 Jun; 63(1):359-63. PubMed ID: 8661226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinephrine or peplomycin combined with hyperthermia in irradiated Lewis lung carcinoma: effects on tumor growth, skin reaction, and lung metastasis.
    Tamai Y; Ohizumi Y; Mori T
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):171-6. PubMed ID: 9300977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
    Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.
    Geldof AA; Mastbergen SC; Henrar RE; Faircloth GT
    Cancer Chemother Pharmacol; 1999; 44(4):312-8. PubMed ID: 10447579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAI: effects on cytotoxic therapies in vitro and in vivo.
    Teicher BA; Holden SA; Chen YN; Ara G; Korbut TT; Northey D
    Cancer Chemother Pharmacol; 1994; 34(6):515-21. PubMed ID: 7923563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
    Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
    Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma.
    Teicher BA; Holden SA; Ara G; Korbut T; Menon K
    Cancer Chemother Pharmacol; 1996; 38(2):169-77. PubMed ID: 8616908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.